Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 202

1.

Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.

Jönsen A, Hjalte F, Willim M, Carlsson KS, Sjöwall C, Svenungsson E, Leonard D, Bengtsson C, Rantapää-Dahlqvist S, Pettersson S, Gunnarsson I, Zickert A, Gustafsson JT, Rönnblom L, Petersson IF, Bengtsson AA, Nived O.

Semin Arthritis Rheum. 2015 Dec 2. pii: S0049-0172(15)00291-7. doi: 10.1016/j.semarthrit.2015.11.013. [Epub ahead of print]

PMID:
26743074
2.

Case definitions in Swedish register data to identify systemic lupus erythematosus.

Arkema EV, Jönsen A, Rönnblom L, Svenungsson E, Sjöwall C, Simard JF.

BMJ Open. 2016 Jan 4;6(1):e007769. doi: 10.1136/bmjopen-2015-007769.

3.

Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort.

Jönsen A, Bengtsson AA, Hjalte F, Petersson IF, Willim M, Nived O.

Lupus. 2015 Oct;24(12):1248-56. doi: 10.1177/0961203315584812. Epub 2015 May 8.

PMID:
25957301
4.

Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.

Lood C, Tydén H, Gullstrand B, Klint C, Wenglén C, Nielsen CT, Heegaard NH, Jönsen A, Kahn R, Bengtsson AA.

PLoS One. 2015 Apr 21;10(4):e0125109. doi: 10.1371/journal.pone.0125109. eCollection 2015.

5.

Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study.

Compagno M, Rekvig OP, Bengtsson AA, Sturfelt G, Heegaard NH, Jönsen A, Jacobsen RS, Eilertsen GØ, Fenton CG, Truedsson L, Nossent JC, Jacobsen S.

Lupus Sci Med. 2014 Apr 1;1(1):e000007. doi: 10.1136/lupus-2013-000007. eCollection 2014.

6.

Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.

Lood C, Tydén H, Gullstrand B, Sturfelt G, Jönsen A, Truedsson L, Bengtsson AA.

PLoS One. 2014 Jun 12;9(6):e99386. doi: 10.1371/journal.pone.0099386. eCollection 2014.

7.

Systemic lupus erythematosus prevalence in Sweden in 2010: what do national registers say?

Simard JF, Sjöwall C, Rönnblom L, Jönsen A, Svenungsson E.

Arthritis Care Res (Hoboken). 2014 Nov;66(11):1710-7. doi: 10.1002/acr.22355.

8.

Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis.

Bolin K, Sandling JK, Zickert A, Jönsen A, Sjöwall C, Svenungsson E, Bengtsson AA, Eloranta ML, Rönnblom L, Syvänen AC, Gunnarsson I, Nordmark G.

PLoS One. 2013 Dec 27;8(12):e84450. doi: 10.1371/journal.pone.0084450. eCollection 2013.

9.

Seeking to reduce nonbeneficial treatment in the ICU: an exploratory trial of proactive ethics intervention*.

Andereck WS, McGaughey JW, Schneiderman LJ, Jonsen AR.

Crit Care Med. 2014 Apr;42(4):824-30. doi: 10.1097/CCM.0000000000000034.

PMID:
24201177
10.

Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus.

Leffler J, Gullstrand B, Jönsen A, Nilsson JÅ, Martin M, Blom AM, Bengtsson AA.

Arthritis Res Ther. 2013 Aug 14;15(4):R84. doi: 10.1186/ar4264.

11.

Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.

Tydén H, Lood C, Gullstrand B, Jönsen A, Nived O, Sturfelt G, Truedsson L, Ivars F, Leanderson T, Bengtsson AA.

Rheumatology (Oxford). 2013 Nov;52(11):2048-55. doi: 10.1093/rheumatology/ket263. Epub 2013 Aug 13.

12.

An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.

Nived O, Hallengren CS, Alm P, Jönsen A, Sturfelt G, Bengtsson AA.

Scand J Rheumatol. 2013;42(5):383-9. doi: 10.3109/03009742.2013.799224. Epub 2013 Jul 5.

PMID:
23829689
13.

Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants.

Leonard D, Svenungsson E, Sandling JK, Berggren O, Jönsen A, Bengtsson C, Wang C, Jensen-Urstad K, Granstam SO, Bengtsson AA, Gustafsson JT, Gunnarsson I, Rantapää-Dahlqvist S, Nordmark G, Eloranta ML, Syvänen AC, Rönnblom L.

Circ Cardiovasc Genet. 2013 Jun;6(3):255-63. doi: 10.1161/CIRCGENETICS.113.000044. Epub 2013 May 9.

14.

Contribution of IKBKE and IFIH1 gene variants to SLE susceptibility.

Wang C, Ahlford A, Laxman N, Nordmark G, Eloranta ML, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jönsen A, Bengtsson AA, Truedsson L, Rantapää-Dahlqvist S, Sjöwall C, Sandling JK, Rönnblom L, Syvänen AC.

Genes Immun. 2013 Jun;14(4):217-22. doi: 10.1038/gene.2013.9. Epub 2013 Mar 28.

PMID:
23535865
15.

Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.

Compagno M, Jacobsen S, Rekvig OP, Truedsson L, Heegaard NH, Nossent J, Jönsen A, Jacobsen RS, Eilertsen GØ, Sturfelt G, Bengtsson AA.

Scand J Rheumatol. 2013;42(4):311-6. doi: 10.3109/03009742.2013.765032. Epub 2013 Mar 16.

PMID:
23496224
16.

The ethics of organ transplantation: a brief history.

Jonsen AR.

Virtual Mentor. 2012 Mar 1;14(3):264-8. doi: 10.1001/virtualmentor.2012.14.3.mhst1-1203. No abstract available.

17.

Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations.

Wang C, Ahlford A, Järvinen TM, Nordmark G, Eloranta ML, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jönsen A, Bengtsson AA, Truedsson L, Eriksson C, Rantapää-Dahlqvist S, Sjöwall C, Julkunen H, Criswell LA, Graham RR, Behrens TW, Kere J, Rönnblom L, Syvänen AC, Sandling JK.

Eur J Hum Genet. 2013 Sep;21(9):994-9. doi: 10.1038/ejhg.2012.277. Epub 2012 Dec 19.

18.

Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.

Vikerfors A, Johansson AB, Gustafsson JT, Jönsen A, Leonard D, Zickert A, Nordmark G, Sturfelt G, Bengtsson A, Rönnblom L, Gunnarsson I, Elvin K, Svenungsson E.

Rheumatology (Oxford). 2013 Mar;52(3):501-9. doi: 10.1093/rheumatology/kes252. Epub 2012 Nov 18.

19.

The clinical ethics consultant: verifying the qualifications of a new type of practitioner in a community hospital.

Andereck WS, McGaughey JW, Jonsen AR.

J Healthc Manag. 2012 Jul-Aug;57(4):264-73; discussion 274-5.

PMID:
22905605
20.

Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.

Foltyn Zadura A, Zipfel PF, Bokarewa MI, Sturfelt G, Jönsen A, Nilsson SC, Hillarp A, Saxne T, Trouw LA, Blom AM.

Arthritis Res Ther. 2012 Aug 15;14(4):R185. doi: 10.1186/ar4016.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk